In i s o l a t e d growth hormone deficiency(i-GH-def) t r e a t e d with GH, d i s p r o p o r t i n a t e l y advanced bony maturation o c c a s i o n a l l y f o llowed i n e a r l y t o mid s t a g e of puberty. W e s t u d i e d t h e e f f e c t of cyproterone acetate(CA1 on a c c e l e r a t e d sexual maturation associa t e d wlth GH therapy f o r i-GH-def. Subjects were 7 p a t i e n t s , ages 14-19 years, and 2 females and 5 males. Four of them r e c e lved 100mg/mYday of CA f o r 1 t o 3 y e a r s . I n a l l , secondery sexual maturation occurred a t 13 t o 16 years of chronological age and a t 9 t o 13 years of bony age(BA). Serum t e s t o s t e r o n e ( T ) l e v e l s r a p i d l y increased a t 2nd grade of Tanner i n male p a t i e n t s (T:530 -1560 n g / d l ) . I n 3 males without CA treatment, bony maturation advanced r a p i d l y from 2nd t o 3rd grade of Tanner and a sensitive period f o r GH therapy was shortened. After a combined therapy o f C A and GH, bony maturation d e c e l e r a t e d and serum T l e v e l s f e l l o f f t o p r e p u b e r t a l l e v e l ( ( 3 0 n g / d l ) . Two females t r e a t e d with C A e x h i b i t e d t h e s i m i l a r e f f e c t . Serum somatomedin-C r e sponses t o GH were s i m i l a r before and a f t e r t h e C A therapy. A r a t i o o f d h e i g h t age/dBA f o r f i r s t one year a f t e r an appearance of secondary sexual c h a r a c t e r i s t i c s was below 0 . 5 I n 3 p a t i e n t s without C A treatment, b u t t h e r a t i o reached 1 o r above In a l l o f 4 t r e a t e d with CA. I n i-GH-def, C A suppressed t h e advance of Bony maturation and prolonged t h e e f f e c t i v e period of GH t h e r apy, and consequently may be a b l e t o make f i n a l height heigher than p r e d i c t e d a d u l t h e l g h t before C A treatment.
The Role of Cyproterone Acetate i n t h e Treatment of I s o l a t e d Growth Hormone Deficiency. Kenji Ohyama, Masatoshi Fujimoto and Kiyohiko Kato Department of P e d i a t r i c s , Yamanashi Medlcal College, Yamanashi 409-38, Japan
In i s o l a t e d growth hormone deficiency(i-GH-def) t r e a t e d with GH, d i s p r o p o r t i n a t e l y advanced bony maturation o c c a s i o n a l l y f o llowed i n e a r l y t o mid s t a g e of puberty. W e s t u d i e d t h e e f f e c t of cyproterone acetate(CA1 on a c c e l e r a t e d sexual maturation associa t e d wlth GH therapy f o r i-GH-def. Subjects were 7 p a t i e n t s , ages 14-19 years, and 2 females and 5 males. Four of them r e c e lved 100mg/mYday of CA f o r 1 t o 3 y e a r s . I n a l l , secondery sexual maturation occurred a t 13 t o 16 years of chronological age and a t 9 t o 13 years of bony age(BA). Serum t e s t o s t e r o n e ( T ) l e v e l s r a p i d l y increased a t 2nd grade of Tanner i n male p a t i e n t s (T:530 -1560 n g / d l ) . I n 3 males without CA treatment, bony maturation advanced r a p i d l y from 2nd t o 3rd grade of Tanner and a sensitive period f o r GH therapy was shortened. After a combined therapy o f C A and GH, bony maturation d e c e l e r a t e d and serum T l e v e l s f e l l o f f t o p r e p u b e r t a l l e v e l ( ( 3 0 n g / d l ) . Two females t r e a t e d with C A e x h i b i t e d t h e s i m i l a r e f f e c t . Serum somatomedin-C r e sponses t o GH were s i m i l a r before and a f t e r t h e C A therapy. A r a t i o o f d h e i g h t age/dBA f o r f i r s t one year a f t e r an appearance of secondary sexual c h a r a c t e r i s t i c s was below 0 . 5 I n 3 p a t i e n t s without C A treatment, b u t t h e r a t i o reached 1 o r above In a l l o f 4 t r e a t e d with CA. I n i-GH-def, C A suppressed t h e advance of Bony maturation and prolonged t h e e f f e c t i v e period of GH t h e r apy, and consequently may be a b l e t o make f i n a l height heigher than p r e d i c t e d a d u l t h e l g h t before C A treatment.
GROWTH HORMONE (CHI SECRETORY PATTERNS IN CHILDREN WITH SHORT
28 STATURE. Gertrude C o s t i n and Francine R. Kaufman. Univ. o f So.
Calif., Sch. of Med., Dept. of Peds., Los Angeles, C a l i f , U.S.A.
T h i r t y -s i x h e a l t h y c h i l d r e n , 24 -16b y e a r s old, ( 2 6 males, 10 females) w i t h s h o r t s t a t u r e , subnormal r a t e of growth and s t i m u l a t e d CH l e v e l s ' 7 ng/rnl, had measurements of CH every 4 h r f o r 24 h r . Based on t h e 24 h r CH c o n c e n t r a t i o n , t h e p a t i e n t s ( p t s ) were separated i n t o 2 groups of 18.
The 24 h r CH c o n c e n t r a t i o n was normal ( > 3 . 0 ng/ml; 8.E. S p i l l i a t i s e t a l , JAMA 1984) i n a l l p t s i n g r i and abnormal i n a l l g r I I p t s . The mean ( i SEM) 24 h r CH concentration, t h e number o f CH pulses/24 h r and t h e mean peak CH a m p l i t u d e were s i g n i f i c a n t l y g r e a t e r ( p < 0.05 t o p < 0 . 0 0 0 5 ) i n g r 1 (4.08 -t 0.23; 4.6 i 0.3 and 7.2 + 0.35) t h a n t h e corresponding values i n g r l l (2.31 t 0.09; 2.27 i 0.34 and 4.4 i 0.33).
The mean h i g h e s t s t i m u l a t e d CH l e v e l i n g r I was 20.1 * 1.7 ng/ml (range 12.5 -39.5 ng/ml) and s i g n i f i c a n t l y g r e a t e r ( p < 0 . 0 1 ) t h a n t h e l e v e l o f 14.5 t 1.13 ng/ml (range 9.5 -25.5 ng/ml) i n g r l l . I n p t s i n g r i t h e mean 24 h r CH c o n c e n t r a t i o n and t h e number o f CH pulses/24 h r were s i g n i f i c a n t l y g r e a t e r ( p < 0 . 0 5 ; p < 0 . 0 0 0 5 ) i n p u b e r t a l (4.61 i 0.45; 5.62 t 0.37) than i n p r e p u b e r t a l p t s (3.65 i 0.12; 3.8 i 0.24) b u t no d i f f e r e n c e s were noted i n p t s i n g r I . SmC l e v e l s ranged from 0.14 t o 1.5 U/ml i n g r I and from 0.10 t o 1.8 U/ml i n g r 1 1 . No s i g n i f i c a n t d i f f e r e n c e s i n SmC l e v e l s were found between t h e 2 groups, however, i n b o t h groups t h e mean SmC l e v e l was g r e a t e r i n p u b e r t a l t h a n i n p r e p u b e r t a l p t s .
The r e s u l t s i n d i c a t e t h a t 1 ) a b n o r m a l i t i e s i n n e u r a r e g u l a t i a n of CH s e c r e t i o n may be a common cause o f s h o r t s t a t u r e , 2) CH responses t o p r o v o c a t i v e s t i m u l i and SmC l e v e l s a r e n o t d i a g n o s t i c o f s u b t l e a b n o r m a l i t i e s i n CH s e c r e t i o n and 3 ) p u b e r t y may augment CH r e l e a s e i n c h i l d r e n w i t h normal 24 h r CH c o n c e n t r a t i o n b u t appears t o have no e f f e c t i n c h i l d r e n w i t h d i s t u r b a n c e s i n CH s e c r e t i o n . Growth response t o hCH therapy may e l u c i d a t e whether d y s r e g v l a t i o n i n CH s e c r e t i o n i s a t r e a t a b l e cause o f s h o r t s t a t u r e .
DECREASE IN CYTOCHRCME P-450 DEPENDENT 3-N-DMETHYLATION OF CAFFEINE MEASURED BY THE
29 CAFFEINE ?>CO= BREATH TE51 t CBI) FOUVYIW GROWTH HORnONE THERAPY IN GROWTH HOMONE (GH) DEFICIENT CHILDREN. Lynne L. Levitskv. George H. Lambert. Dale A. S c h o e l l e r , Deborah V. Edidin, P r i t z k e r Sch. of Hed., Univ. of Chicago, Michael Reese Hosp., Dept. of Pediat. and Medicine; Chicago, USA S i g n i f i c a n t changes i n hepatic drug c l e a r a n c e occur i n t h e t r a n s i t i o n f r a n childhood t o adulthood. These changes probably p a r a l l e l t h e functional c a p a c i t y of t h e h e p a t i c cytochrane P-450 dependent mixed function oxidase (MFO) system. GH dec r e a s e s hepatic MFO a c t i v i t y i n animals and may a c t s i m i l a r l y i n humans.
Caffeine l a b e l l e d with s t a b l e j 3 C has been shown t o be a s u b s t r a t e f o r t h e MFO system.
Five G H d e f i c i e n t c h i l d r e n underwent CBT, with c o l l e c t i o n s of expired a i r f o r j3C02 enrichment a n a l y s i s following i n g e s t i o n of j3C-c a f f e i n e ( 3 mg/Kg) before, and 4-5 weeks following GH 0.1 u/Kg S.C. t . i . w . A l l c h i l d r e n showed a decrease i n X '3C02 dose exhaled over 2 hours following G H administration: Pre 9 . 1~1 . 5 , Post 7 . 3~2 . 9 ( H . 0 5 , paired t -t e s t ) The CBT is a s a f e e f f e c t i v e technique f o r t h e measurement of t h e hepatic MFO system. Clonidine, a presumed a 2 agonist, is a potent stimulus for GH in man and gonadotropins in rodents. T o assess t h e a c u t e and chronic e f f e c t s of this drug on GH and gonadotropins in adolescents, we studied 4 boys in early t o mi&puberty, sampling blood every 15-20 min for LH and FSH (2 i SE mIU/ml) and hourly for GH, before a n d a f t e r one or two oral ~1 5 m g / m 2 doses of clonidine.
N-demethylation of c a f f e i n e is decreased by GH therapy i n GH d e f i c i e n t c h i l d r e n . The c a p a c i t y f o r N-demethylation is h i g h e s t i n prepubertal c h i l d r e n . T h i s may p a r t i a l l y c o r r e l a t e with changing p a t t e r n s o f G H r e l e a s e . ACUTE AND CHRONIC EFFECTS O F CLONIDINE ON GROWTH HORMONE AND GONADOTROPIN
( 20.4 k0.3 Clonidine had no e f f e c t on LH pulse frequency or t h e circadian pattern of LH, FSH or GH secretion. It was consistently followed within 2h by a GH peak comparable t o t h e spontaneous pulses. This e f f e c t on GH was maintained in pt. #4 a f t e r chronic therapy. We conclude: 1 ) clonidine has a modest effect, if any, on gonadotropins a t this s t a g e of human puberty; 2) growth should be followed closely in adolescents on clonidine therapy.
GROWTH HORMONE SECRETORY PATTERNS -AID TO 3 1 DIAGNOSIS O F GROWTH PROBLEMS. Nancy J. Hopwood, George E. Bacon, Inese Z. Beitins, Paula M. Hale, Tarlna M. Mendes, Robert P. Kelch, University of Michigan Medical C e n t e r , Department of Pediatrics, Ann Arbor, MI USA Since GH responses t o provocative (PGH) stimuli a r e often not reflective of physiological GH secretion, PGH was compared with integrated physiological GH secretion (ICGH) in 133 children and adolescents ages 4-18, with abnormal growth (<Sth o r >95th % for height and/or abnormal growth velocity). ICGH was determined by continuous ambulatory blood withdrawal pump (collected in one hr aliquots) over 12 h (1800-0600) o r 24 h (1800-1800) in 87, o r by 12 h intermittent q 20 min sampling (1800-0600) in 46 patients. The following morning all children had either arginine-insulin (AI) induced hypoglycemia (118) o r oral clonidine (C) (15) tests. Serum somatomedin C , T/E2, bone a g e and Tq were also correlated with growth velocity and GH responses. In 33, 24 h ICGH correlated highly with, but was not more informative than 12 h ICGH (1800-0600) performed in all patients. Discordant GH levels (PGH vs ICGH, x and peaks) were present in 47 of 120 (40-50% of children with constitutional delay (CD) of growth), depending on t h e criteria for normality used. Low ICGH (<2 nglml) was seen in 42, and borderline ICGH (2-3 ng/ml) in 21. Low (<7 ng/ml) o r borderline (7-10 mg/ml) GH responses t o A1 o r C were seen in 48 and 19 children respectively. ICGH was useful in excluding a Dx of GH deficiency (GHD) in 14 patients with low PGH, while t h e Dx GHD was further substantiated in 26 patients. ICGH proved most valuable in patients with CD-delayed adolescence andlor emotional stress where "transient" GHD and discordant GH values a r e o f t e n obtained on pharmacologic testing.
LONGITUDINAL HEIGHT AND HEIGHT VELOCITY STANDARDS FOR NORTH AMERICAN CHILDREN:
32 CHARTS ALLOWING FOR EARLY AND LATE MATURATION. J a m e s M. T a n n e r a n d P e t e r S . W. D a v i e s , U n i v e r s i t y o f London I n s t i t u t e o f C h i l d H e a l t h , D e p a r t m e n t o f G r o w t h a n d D e v e l o p m e n t , L o n d o n , U.K.
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